lobbying_activities: 2461663
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2461663 | 8c0747c5-2daa-4160-aa22-0d50334767f3 | Q2 | KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS) | 401105192 | CVS HEALTH | 2020 | second_quarter | PHA | Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care. Issues related to continuation of prescription drug access and testing during COVID crisis. | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2020-07-07T08:38:32.213000-04:00 |